Private Ocean LLC acquired a new position in shares of Danaher Co. (NYSE:DHR) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 270 shares of the conglomerate’s stock, valued at approximately $39,000.
Other large investors also recently modified their holdings of the company. Barings LLC raised its holdings in shares of Danaher by 8.7% during the second quarter. Barings LLC now owns 11,922 shares of the conglomerate’s stock worth $1,703,000 after acquiring an additional 952 shares during the period. Capital Advisors Ltd. LLC grew its position in Danaher by 527.5% in the second quarter. Capital Advisors Ltd. LLC now owns 320 shares of the conglomerate’s stock valued at $46,000 after purchasing an additional 269 shares in the last quarter. Sullivan Bruyette Speros & Blaney LLC grew its position in Danaher by 5.2% in the second quarter. Sullivan Bruyette Speros & Blaney LLC now owns 14,598 shares of the conglomerate’s stock valued at $2,086,000 after purchasing an additional 717 shares in the last quarter. Lenox Wealth Advisors LLC grew its position in Danaher by 231.3% in the second quarter. Lenox Wealth Advisors LLC now owns 1,302 shares of the conglomerate’s stock valued at $186,000 after purchasing an additional 909 shares in the last quarter. Finally, Asahi Life Asset Management CO. LTD. bought a new position in Danaher in the second quarter valued at $177,000. Institutional investors and hedge funds own 78.30% of the company’s stock.
Shares of DHR traded up $0.73 during midday trading on Friday, reaching $135.23. The stock had a trading volume of 1,633,369 shares, compared to its average volume of 2,487,994. The firm has a 50 day simple moving average of $139.07 and a 200-day simple moving average of $138.28. Danaher Co. has a one year low of $94.59 and a one year high of $147.33. The firm has a market cap of $95.87 billion, a PE ratio of 29.92, a P/E/G ratio of 2.24 and a beta of 0.92. The company has a current ratio of 3.43, a quick ratio of 3.09 and a debt-to-equity ratio of 0.52.
The company also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.50%. The ex-dividend date of this dividend was Thursday, September 26th. Danaher’s dividend payout ratio (DPR) is presently 15.04%.
DHR has been the subject of a number of analyst reports. Royal Bank of Canada set a $134.00 target price on shares of Danaher and gave the company a “hold” rating in a research report on Friday, July 19th. Robert W. Baird raised their target price on shares of Danaher from $131.00 to $148.00 and gave the company an “outperform” rating in a research report on Friday, July 19th. Argus raised their target price on shares of Danaher to $165.00 and gave the company a “buy” rating in a research report on Tuesday, July 23rd. Piper Jaffray Companies raised their target price on shares of Danaher from $148.00 to $153.00 and gave the company a “neutral” rating in a research report on Thursday, July 18th. Finally, ValuEngine downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Four research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Danaher currently has a consensus rating of “Buy” and an average price target of $145.86.
In other news, Chairman Mitchell P. Rales acquired 2,500 shares of the firm’s stock in a transaction dated Friday, August 23rd. The stock was bought at an average price of $139.52 per share, with a total value of $348,800.00. Following the transaction, the chairman now directly owns 3,030,453 shares in the company, valued at approximately $422,808,802.56. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 11.40% of the company’s stock.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Further Reading: What is the CBOE Russell 2000® Volatility Index?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.